Studies: Gilead HIV drugs prevent transmission

Two new studies show that AIDS drugs made by Gilead Sciences can prevent heterosexuals from acquiring HIV, adding to a growing number of new methods to slow the spread of the virus worldwide. Report

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.